These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 9219386)
21. The neurobiological basis for partial agonist treatment of nicotine dependence: varenicline. Foulds J Int J Clin Pract; 2006 May; 60(5):571-6. PubMed ID: 16700857 [TBL] [Abstract][Full Text] [Related]
22. Gradual versus abrupt quitting among French treatment-seeking smokers. Baha M; Le Faou AL Prev Med; 2014 Jun; 63():96-102. PubMed ID: 24657328 [TBL] [Abstract][Full Text] [Related]
23. Nicotine Dependence and Willingness to Quit Smoking in Vascular Surgery Patients. Smeds MR; Privratsky A; Thrush CR; Barone CP; Escobar GA; Ali AT; Moursi MM Ann Vasc Surg; 2017 Nov; 45():144-153. PubMed ID: 28647633 [TBL] [Abstract][Full Text] [Related]
24. Treating smokers before the quit date: can nicotine patches and denicotinized cigarettes reduce cravings? Rezaishiraz H; Hyland A; Mahoney MC; O'Connor RJ; Cummings KM Nicotine Tob Res; 2007 Nov; 9(11):1139-46. PubMed ID: 17978987 [TBL] [Abstract][Full Text] [Related]
25. [Methods and results of smoking cessation in cancer smoker's]. Dautzenberg B Bull Cancer; 2012 Nov; 99(11):1007-15. PubMed ID: 23131278 [TBL] [Abstract][Full Text] [Related]
26. Molecular Mechanisms Associated with Nicotine Pharmacology and Dependence. Fowler CD; Turner JR; Imad Damaj M Handb Exp Pharmacol; 2020; 258():373-393. PubMed ID: 31267166 [TBL] [Abstract][Full Text] [Related]
27. Utilization of evidence-based smoking cessation treatments by psychiatric inpatient smokers with depression. Strong DR; Uebelacker L; Fokas K; Saritelli J; Matsko S; Abrantes AM; Schonbrun Y J Addict Med; 2014; 8(2):77-83. PubMed ID: 24562400 [TBL] [Abstract][Full Text] [Related]
29. Lower ß2*-nicotinic acetylcholine receptor availability in smokers with schizophrenia. D'Souza DC; Esterlis I; Carbuto M; Krasenics M; Seibyl J; Bois F; Pittman B; Ranganathan M; Cosgrove K; Staley J Am J Psychiatry; 2012 Mar; 169(3):326-34. PubMed ID: 22193533 [TBL] [Abstract][Full Text] [Related]
30. Four beliefs that may impede progress in the treatment of smoking. Hughes JR Tob Control; 1999; 8(3):323-6. PubMed ID: 10599578 [TBL] [Abstract][Full Text] [Related]
31. Why some people smoke and others do not: new perspectives. Pomerleau OF; Collins AC; Shiffman S; Pomerleau CS J Consult Clin Psychol; 1993 Oct; 61(5):723-31. PubMed ID: 8245270 [TBL] [Abstract][Full Text] [Related]
32. Society for Research on Nicotine and Tobacco. Perkins KA; Benowitz N; Henningfield J; Newhouse P; Pomerleau O; Swan G Addiction; 1996 Jan; 91(1):129-44. PubMed ID: 8822021 [TBL] [Abstract][Full Text] [Related]
33. Consensus statement on smoking cessation in patients with pain. Iida H; Yamaguchi S; Goyagi T; Sugiyama Y; Taniguchi C; Matsubara T; Yamada N; Yonekura H; Iida M J Anesth; 2022 Dec; 36(6):671-687. PubMed ID: 36069935 [TBL] [Abstract][Full Text] [Related]
34. Contribution of CNS nicotine metabolites to the neuropharmacological effects of nicotine and tobacco smoking. Crooks PA; Dwoskin LP Biochem Pharmacol; 1997 Oct; 54(7):743-53. PubMed ID: 9353128 [TBL] [Abstract][Full Text] [Related]
35. Smoking and ischemic stroke: a role for nicotine? Hawkins BT; Brown RC; Davis TP Trends Pharmacol Sci; 2002 Feb; 23(2):78-82. PubMed ID: 11830264 [TBL] [Abstract][Full Text] [Related]
36. Recent advances in nicotine and tobacco research. Ninth SRNT annual meeting. New Orleans, Louisiana, USA. 19-22 February 2003. Klein LC; Eissenberg T Nicotine Tob Res; 2003 Oct; 5(5):761-94. PubMed ID: 14577993 [TBL] [Abstract][Full Text] [Related]
37. [Relation between tobacco smoking and pain: A narrative review of the scientific literature]. Balayssac D Rev Mal Respir; 2021 Mar; 38(3):269-277. PubMed ID: 33648775 [TBL] [Abstract][Full Text] [Related]
38. Nicotine, body weight and potential implications in the treatment of obesity. Li MD; Kane JK; Konu O Curr Top Med Chem; 2003; 3(8):899-919. PubMed ID: 12678839 [TBL] [Abstract][Full Text] [Related]
39. Neurobiological Determinants of Tobacco Smoking in Schizophrenia. Lucatch AM; Lowe DJE; Clark RC; Kozak K; George TP Front Psychiatry; 2018; 9():672. PubMed ID: 30574101 [No Abstract] [Full Text] [Related]
40. Potential contribution of aromatase inhibition to the effects of nicotine and related compounds on the brain. Biegon A; Alia-Klein N; Fowler JS Front Pharmacol; 2012; 3():185. PubMed ID: 23133418 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]